Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

The convention highlighted knowledge sharing, networking, and the importance of active participation in dermatology.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Testosterone may influence COVID-19 severity and outcomes.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Spironolactone can reduce hair growth in women with hirsutism.

Flutamide reduces hair growth better but has more side effects.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.